Spyre Therapeutics Inc: Stifel raises target price to $131 from $123
SYRE•Stifel raised its target price for Spyre Therapeutics to $131 from $123.
Related News
Block, Inc.: Clear Street raises target price to $86 from $82
XYZ•
Wayfair Q3 net income swings to $62 million profit
W•
Waters: Deutsche Bank raises target price to $460 from $440
WAT•
Natera's Signatera detects head and neck cancer recurrence median 4.3 months before imaging in study
NTRA•
Tonix Pharmaceuticals presents at Guggenheim's Healthcare Innovation Conference
TNXP•